JenaValve Technology Raises $62.5 Mln in Series C Financing
JenaValve Technology said Tuesday that it has closed $62.5 million in Series C financing. The lead investor was Belgium-based Gimv, a publicly traded investment company. New investors Beijing-based Legend Capital and Omega Funds also participated in the round as did current investors Edmond de Rothschild Investment Partners of Paris, Atlas Venture Fund, NeoMed Management, VI Partners AG and Sunstone Capital A/S. Based in Munich, Germany, JenaValve Technology is a provider of transcatheter aortic valve implantation systems to treat patients suffering from aortic valve disease.
23 July 2013•4 mins read
